AnalystsGeorge SellersGeorge Sellers's Stock Forecasts
AnalystsGeorge Sellers
Sectors:
Analyst Ranking
Bottom 5%
#4212 out of 4426 analysts
Average Return
-33.42%
Win Rate
22%7 out of 32
Risk vs Reward
Poor
Good
George Sellers's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Glaukos CorpGKOS | +54.14% | $41.28 | $63.63 | 2022-12-28 - 2023-12-08 | Strong Buy |
Glaukos CorpGKOS | +25.83% | $50.57 | $63.63 | 2023-05-04 - 2023-12-08 | Strong Buy |
Glaukos CorpGKOS | +21.96% | $53.78 | $65.59 | 2022-10-14 - 2023-10-13 | Strong Buy |
Apyx Medical CorpAPYX | +20.80% | $1.76 | $2.12 | 2023-11-10 - 2023-12-08 | Strong Buy |
Teleflex IncTFX | +20.21% | $192.23 | $231.08 | 2023-10-11 - 2023-12-08 | Strong Buy |
George Sellers Analyst Color
Get additional color on George Sellers's coverage of popular stocks
George Sellers's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Apyx Medical CorpAPYX | 2 | Strong Buy | $5.00 | +135.85% | Maintains | a month ago |
Teleflex IncTFX | 6 | Strong Buy | $275.00 | +19.01% | Reiterates | a month ago |
Vericel CorpVCEL | 1 | Strong Buy | $44.00 | +29.95% | Reiterates | 3 months ago |
Treace Medical Concepts IncTMCI | 4 | Hold | $25.00 | +163.16% | Reiterates | 3 months ago |
Staar Surgical CoSTAA | 6 | Strong Buy | $57.00 | +70.66% | Reiterates | 4 months ago |
Anika Therapeutics IncANIK | 4 | Hold | $23.00 | +2.40% | Maintains | 4 months ago |
Establishment Labs Holdings IncESTA | 5 | Strong Buy | $89.00 | +283.13% | Reiterates | 5 months ago |
Cutera IncCUTR | 6 | Strong Buy | $42.00 | +1,742.11% | Reiterates | 6 months ago |
Glaukos CorpGKOS | 4 | Strong Buy | $71.00 | +11.58% | Reiterates | 7 months ago |
Paragon 28 IncFNA | 2 | Strong Buy | $23.00 | +100.17% | Reiterates | 8 months ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.